A Study of CDX-0159 in Patients With Prurigo Nodularis
Completed · Phase 1 · Has a placebo group
Conditions studied: Prurigo Nodularis
In brief
The purpose of the study is to explore the safety, clinical effect, pharmacodynamics, and pharmacokinetics of CDX-0159 (barzolvolimab) in patients with Prurigo Nodularis.
Key facts
- Study ID
- NCT04944862
- Run by
- Celldex Therapeutics
- People needed
- 24
- Starts
- 2021-11-08
- Expected to finish
- 2023-07-31
- Last updated by the study team
- 2023-08-14
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Desert Sky Dermatology — Tempe, Arizona, United States
- University of Miami, Dermatology Clinical Trials Unit — Miami, Florida, United States
- Revival Research Institute, LLC — Troy, Michigan, United States
- University of New Mexico — Albuquerque, New Mexico, United States
- Markowitz Medical/Optiskin — New York, New York, United States
- Central Sooner Research — Norman, Oklahoma, United States
- Center for Clinical Studies, LTD.LLP — Houston, Texas, United States
- Charité Centrum für Innere Medizin und Dermatologie, Institute of Allergology (IFA) — Berlin, Germany
- Katholisches Klinikum Bochum gGmbH, Dermatologische Studienambulanz — Bochum, Germany
- Universitatsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik fur Dermatologie — Dresden, Germany
- Universitätsklinikum Frankfurt Klinik für Dermatologie, Venerologie und Allergologie Klinische Forschung — Frankfurt, Germany
- Universitätsklinikum Erlangen Hautklinik — Mainz, Germany
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz Hautklinik, Clinical Research Center — Mainz, Germany
- Universitaetsklinikum Muenster (UKM) - Klinik für Hautkrankheiten — Münster, Germany
- MT Medic Specjalistyczna Praktyka Lekarska — Krosno, Poland
- IP Clinic Sp. z o.o. — Lodz, Poland
- Centrum Medyczne Ginemedica — Wroclaw, Poland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.